Julia Kuder
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
Papers in
- Surgery 20
- Lipoproteins and Cardiovascular Health 16
- Coronary Interventions and Diagnostics 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Atrial Fibrillation Management and Outcomes 6
- Co-authors
- Sabina A. Murphy (32 shared papers)Marc S. Sabatine (38 shared papers)Deepak L. Bhatt (13 shared papers)Marc P. Bonaca (12 shared papers)Christian T. Ruff (10 shared papers)Lawrence A. Leiter (7 shared papers)Stephen D. Wiviott (8 shared papers)Ingrid Gause‐Nilsson (6 shared papers)
- Journals
- Journal of the American College of Cardiology (14 papers)Circulation (12 papers)JAMA Cardiology (4 papers)European Heart Journal (3 papers)New England Journal of Medicine (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Julia Kuder
61 papers receiving 9.0k citations
Julia Kuder's Hit Papers
Peers
Comparison fields: 5 of 135
- Endocrinology, Diabetes and Metabolism 4.3k
- Cardiology and Cardiovascular Medicine 2.5k
- Internal Medicine 361
- Surgery 2.9k
- Nephrology 389
Countries citing papers authored by Julia Kuder
This map shows the geographic impact of Julia Kuder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Kuder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Kuder more than expected).
Fields of papers citing papers by Julia Kuder
This network shows the impact of papers produced by Julia Kuder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Kuder. The network helps show where Julia Kuder may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Kuder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2018 | 4394 |
| 2 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 510 |
| 3 | Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Hit paper breakdown → | 2017 | 413 |
| 4 | Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Hit paper breakdown → | 2015 | 366 |
| 5 | Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease Hit paper breakdown → | 2022 | 351 |
| 6 | Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus Hit paper breakdown → | 2020 | 331 |
| 7 | Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial Hit paper breakdown → | 2015 | 303 |
| 8 | 2016 | 254 | |
| 9 | Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Hit paper breakdown → | 2019 | 243 |
| 10 | Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease Hit paper breakdown → | 2022 | 233 |
| 11 | 2016 | 214 | |
| 12 | 2018 | 172 | |
| 13 | 2013 | 150 | |
| 14 | 2018 | 89 | |
| 15 | 2020 | 87 | |
| 16 | 2016 | 85 | |
| 17 | 2009 | 76 | |
| 18 | 2010 | 70 | |
| 19 | 2015 | 53 | |
| 20 | 2013 | 53 |
About Julia Kuder
Julia Kuder is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Physiology, having authored 62 papers that have together received 9.2k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (16 papers), Obesity, Physical Activity, Diet (7 papers), Diabetes Treatment and Management (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Atrial Fibrillation Management and Outcomes (6 papers), Coronary Interventions and Diagnostics (5 papers), Cancer, Lipids, and Metabolism (3 papers) and Physical Activity and Health (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.3k citations), Cardiology and Cardiovascular Medicine (2.5k citations), Internal Medicine (361 citations), Surgery (2.9k citations) and Nephrology (389 citations). Julia Kuder has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Sabina A. Murphy, Marc S. Sabatine, Deepak L. Bhatt, Marc P. Bonaca, Christian T. Ruff, Lawrence A. Leiter, Stephen D. Wiviott, Ingrid Gause‐Nilsson, Darren K. McGuire and John Wilding. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, JAMA Cardiology, European Heart Journal and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.